Subscription-Based Healthcare Services Expand Offerings Amid Growth and Quality Concerns
Companies like Hims & Hers, Ro, and Lemonaid Health now treat a wider range of health issues, but critics question the quality of care provided.
- Subscription-based healthcare services like Hims & Hers, Ro, and Lemonaid Health are expanding beyond their initial offerings of treatments for hair loss, acne, and birth control to include a wider range of health issues.
- Hims recently launched a weight-loss program starting at $79 a month without insurance, while Lemonaid began treating seasonal affective disorder last winter for $95 a month.
- These companies promise to address two common difficulties in the U.S.: access to healthcare and prescription refills, but there are concerns about the quality of care provided.
- Hims, which is publicly traded, has topped 1.4 million subscribers this year and expects to pull in at least $1.2 billion in annual sales by 2025.
- Critics argue that these companies are more focused on selling drugs to consumers than providing comprehensive medical care, and there are concerns about the potential for misdiagnosis and inadequate monitoring of patients on regular medications.